# RBX-1 Target Analysis Summary

## Basic Information
- **UniProt ID**: P62877
- **Gene Name**: RBX1
- **Full Name**: RING-box protein 1 (ROC1)
- **Length**: 108 amino acids
- **Molecular Weight**: 12,274 Da
- **Organism**: Homo sapiens

## Sequence
```
MAAAMDVDTPSGTNSGAGKKRFEVKKWNAVALWAWDIVVDNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKTRQVCPLDNREWEFQKYGH
```

## Structural Features

### Domain Architecture
- **N-terminal region (residues 1-39)**: Intrinsically disordered region
- **C-terminal RING-H2 domain (residues 40-108)**: Structured domain with zinc coordination
- **RING-type zinc finger**: Essential for E3 ubiquitin ligase activity, coordinates 3 zinc ions in cross-brace arrangement

### Available Structures
| PDB ID | Title | Resolution | Method | Year |
|--------|-------|------------|---------|------|
| 1LDJ | SCF Ubiquitin Ligase Complex (CUL1-RBX1-SKP1-SKP2) | 3.0 Å | X-RAY | 2002 |
| 1U6G | ? | ? | X-RAY | ? |
| 2HYE | ? | ? | X-RAY | ? |
| 2LGV | ? | ? | X-RAY | ? |
| 4F52 | ? | ? | X-RAY | ? |

*Note: AlphaFold structure not available for P62877*

## Functional Information

### Primary Function
E3 ubiquitin ligase component of multiple cullin-RING-based E3 ubiquitin-protein ligase (CRLs) complexes. Mediates ubiquitination and proteasomal degradation of target proteins involved in:
- Cell cycle progression
- Signal transduction
- Transcription
- DNA repair

### Key Complexes
- **SCF complexes**: SKP1-CUL1-F-box protein complexes
- **CRL2 complexes**: CUL2-based complexes with Elongin BC
- **CRL3 complexes**: CUL3-BTB protein complexes
- **CRL4 complexes**: CUL4-DDB1-based complexes
- **CRL5 complexes**: CUL5-based complexes

### Cancer Relevance
- Overexpressed in multiple human cancers
- Controls turnover of tumor suppressors and oncogenes
- Essential for ubiquitin-mediated protein degradation
- Potential therapeutic target

## Design Challenges

### Structural Challenges
1. **Intrinsically disordered region**: N-terminal 39 residues lack fixed structure
2. **Metal coordination**: RING domain requires proper zinc coordination
3. **Dynamic surface**: Combination of flexible and rigid regions
4. **Hub protein**: Multiple binding partners (cullins, E2 enzymes, NEDD8)

### Design Opportunities
1. **RING domain targeting**: Well-structured C-terminal domain
2. **Allosteric sites**: Potential binding sites away from active site
3. **Interface disruption**: Target protein-protein interactions
4. **Multiple epitopes**: Different binding modes possible

## Next Steps
1. Analyze PDB structures to identify binding sites
2. Perform structural analysis of RING domain
3. Identify potential allosteric sites
4. Design binder generation pipeline